Ping Zhang

Ping Zhang

Auto-generated profile, based on publicly available information

Ping Zhang

Griffith Centre for Mental Health, Griffith University, Gold Coast, Australia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
LZLiang Zhao
Liang Zhao
EGEvgeny A. Glazov
Evgeny A. Glazov
PRPattabiraman Diwakar R
Pattabiraman Diwakar R
FAFaisal Al-Owaidi
Faisal Al-Owaidi
PZPing Zhang
Ping Zhang
TGThomas J. Gonda
Thomas J. Gonda
To gain insight into the mechanisms by which the Myb transcription factor controls normal hematopoiesis and particularly, how it contributes to leukemogenesis, we mapped the genome-wide occupancy of Myb by chromatin immunoprecipitation followed by massively parallel sequencing (ChIP-Seq) in ERMYB myeloid progenitor cells. By integrating the genome occupancy data with whole genome expression profiling data, we identified a Myb-regulated transcriptional program. Gene signatures for leukemia stem cells, normal hematopoietic stem/progenitor cells and myeloid development were overrepresented in 2368 Myb regulated genes. Of these, Myb bound directly near or within 793 genes. Myb directly activates some genes known critical in maintaining hematopoietic stem cells, such as Gfi1 and Cited2. Importantly, we also show that, despite being usually considered as a transactivator, Myb also functions to repress approximately half of its direct targets, including several key regulators of myeloid differentiation, such as Sfpi1 (also known as Pu.1), Runx1, Junb and Cebpb. Furthermore, our results demonstrate that interaction with p300, an established coactivator for Myb, is unexpectedly required for Myb-mediated transcriptional repression. We propose that the repression of the above mentioned key pro-differentiation factors may contribute essentially to Myb’s ability to suppress differentiation and promote self-renewal, thus maintaining progenitor cells in an undifferentiated state and promoting leukemic transformation.

1 March 2010 in Cell Cycle
Verified
Journal Article
Open access
MLMaria A. Lagarkova
Maria A. Lagarkova
MSMaria V. Shutova
Maria V. Shutova
ABAlexandra N. Bogomazova
Alexandra N. Bogomazova
EVEkaterina M. Vassina
Ekaterina M. Vassina
EGEvgeny A. Glazov
Evgeny A. Glazov
SKSergey Kiselev
Sergey Kiselev
(2010). Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle: Vol. 9, No. 5, pp. 937-946.

8 December 2014 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
PJPiers Johnson
Piers Johnson
LVLuke Vandewater
Luke Vandewater
WWWilliam Wilson
William Wilson
PMPaul Maruff
Paul Maruff
GSGreg Savage
Greg Savage
PZPing Zhang
Ping Zhang
Assessment of risk and early diagnosis of Alzheimer's disease (AD) is a key to its prevention or slowing the progression of the disease. Previous research on risk factors for AD typically utilizes statistical comparison tests or stepwise selection with regression models. Outcomes of these methods tend to emphasize single risk factors rather than a combination of risk factors. However, a combination of factors, rather than any one alone, is likely to affect disease development. Genetic algorithms (GA) can be useful and efficient for searching a combination of variables for the best achievement (eg. accuracy of diagnosis), especially when the search space is large, complex or poorly understood, as in the case in prediction of AD development. Multiple sets of neuropsychological tests were identified by GA to best predict conversions between clinical categories, with a cross validated AUC (area under the ROC curve) of 0.90 for prediction of HC conversion to MCI/AD and 0.86 for MCI conversion to AD within 36 months. This study showed the potential of GA application in the neural science area. It demonstrated that the combination of a small set of variables is superior in performance than the use of all the single significant variables in the model for prediction of progression of disease. Variables more frequently selected by GA might be more important as part of the algorithm for prediction of disease development.

17 November 2004 in Pattern Recognition Letters
Verified
Journal Article
Closed access
PZPing Zhang
Ping Zhang
BVBrijesh Verma
Brijesh Verma
KKKuldeep Kumar
Kuldeep Kumar

24 January 2018 in Sports Medicine
Verified
Journal Article
Open access
PDF file
CCCandice Colbey
Candice Colbey
ACAmanda J. Cox
Amanda J. Cox
DPDavid Pyne
David Pyne
PZPing Zhang
Ping Zhang
ACAllan W. Cripps
Allan W. Cripps
NWNicholas West
Nicholas West
Upper respiratory symptoms remain the most common illness in athletes. Upper respiratory symptoms during heavy training and competition may impair performance. Preventing illness is the primary reason for the use of supplements, such as probiotics and prebiotics, for maintaining or promoting gut health and immune function. While exercise-induced perturbations in the immune system may increase susceptibility to illness and infection, growing evidence indicates that upper respiratory symptoms are related to a breakdown in the homeostatic regulation of the mucosal immune system of the airways. Balancing protection of the respiratory tract with normal physiological functioning requires dynamic orchestration between a wide array of immune parameters. The intestinal microbiota regulates extra-intestinal immunity via the common mucosal immune system and new evidence implicates the microbiota of the nose, mouth and respiratory tract in upper respiratory symptoms. Omics’ approaches now facilitate comprehensive profiling at the molecular and proteomic levels to reveal new pathways and molecules of immune regulation. New targets may provide for personalised nutritional and training interventions to maintain athlete health.

7 June 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAyenachew Bezawork-Geleta
Ayenachew Bezawork-Geleta
HWHe Wen
He Wen
LDLanfeng Dong
Lanfeng Dong
BYBing Yan
Bing Yan
JVJelena Vider
Jelena Vider
JNJiri Neuzil
Jiri Neuzil
Cell growth and survival depend on a delicate balance between energy production and synthesis of metabolites. Here, we provide evidence that an alternative mitochondrial complex II (CII) assembly, designated as CIIlow, serves as a checkpoint for metabolite biosynthesis under bioenergetic stress, with cells suppressing their energy utilization by modulating DNA synthesis and cell cycle progression. Depletion of CIIlow leads to an imbalance in energy utilization and metabolite synthesis, as evidenced by recovery of the de novo pyrimidine pathway and unlocking cell cycle arrest from the S-phase. In vitro experiments are further corroborated by analysis of paraganglioma tissues from patients with sporadic, SDHA and SDHB mutations. These findings suggest that CIIlow is a core complex inside mitochondria that provides homeostatic control of cellular metabolism depending on the availability of energy.